| Fund ID | 805-7281770620 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 3% |
| Owned by funds of funds | 14% |
| Owned by non-U.S. persons | 20% |
| Fund | Type | Gross assets |
|---|---|---|
| Orbimed Private Investments IX, LP | Other Private | $2.03B |
| Orbimed Private Investments VIII, LP | Other Private | $1.69B |
| Orbimed Asia Partners III, L.P. | Other Private | $1.66B |
Orbimed Royalty & Credit Opportunities III, LP reports $630 million in gross assets, among the top 11% of private funds by size.
The stated minimum investment is $450,000.
Orbimed Royalty & Credit Opportunities III, LP is managed by Orbimed Advisors LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.